Suppression of growth hormone (GH) hypersecretion due to ectopic GH- releasing hormone (GHRH) by a selective GHRH antagonist

Journal of Clinical Endocrinology and Metabolism

Volumn 82, Issue 2, 1997, Pages 634-637

  Jaffe, Craig A ^a,c   DeMott Friberg, Roberta ^a   Frohman, Lawrence A ^b   Barkan, Ariel L ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^c UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BROMOCRIPTINE; GROWTH HORMONE; GROWTH HORMONE RELEASING FACTOR; GROWTH HORMONE RELEASING FACTOR DERIVATIVE; OCTREOTIDE;

ACROMEGALY; ADULT; ARTICLE; CASE REPORT; CLINICAL FEATURE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; ECTOPIC HORMONE PRODUCTION; GROWTH HORMONE BLOOD LEVEL; GROWTH HORMONE RELEASE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MALE; PRIORITY JOURNAL; PULSATILE HORMONE RELEASE;

ACROMEGALY; ADULT; CARCINOID TUMOR; GROWTH HORMONE-RELEASING HORMONE; HUMAN GROWTH HORMONE; HUMANS; MALE; OSMOLAR CONCENTRATION; PULSATILE FLOW; TIME FACTORS;

FORMICIDAE;

EID: 0031035906     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.82.2.634     Document Type: Article

References (26)

1. Plotsky PM, Vale W. 1985 Patterns of growth hormone-releasing factor and somatostatin secretion into the hypophysial-portal circulation of the rat. Science. 230:461-463.
2. Frohman LA, Downs TR, Clarke IJ, Thomas GB. 1991 Measurement of growth hormone-releasing hormone and somatostatin in hypothalamic-portal plasma of unanesthetized sheep. J Clin Invest. 86:17-24.
3. Thomas GB, Cummins JT, Francis H, Sudbury AW, McCloud PI, Clarke IJ. 1991 Effect of restricted feeding on the relationship between hypophysial portal concentrations of growth hormone (GH)-releasing factor and somatostatin, and jugular concentrations of GH in ovariectomized ewes. Endocrinology. 128:1151-1158.
4. Cataldi M, Magnan E, Guillaume V, et al. 1994 Relationship between hypophyseal portal GHRH and somatostatin and peripheral GH levels in conscious sheep. J Endocrinol Invest. 17:717-722.
5. Vance ML, Kaiser DL, Evans WS, et al. 1985 Pulsatile growth hormone secretion in normal man during a continuous 24-hour infusion of human growth hormone releasing factor (1-40). J Clin Invest. 75:1584-1590.
6. Ho PJ, Jaffe CA, Friberg RD, Chandler WF, Barkan AL. 1994 Persistence of rapid growth hormone (GH) pulsatility after successful removal of GH-producing pituitary tumors. J Clin Endocrinol Metab. 78:1403-1410.
7. Jaffe CA, DeMott Friberg R, Barkan AL. 1993 Suppression of growth hormone (GH) secretion by a selective GH-releasing hormone (GHRH) antagonist: direct evidence for involvement of endogenous GHRH in the generation of GH pulses. J Clin Invest. 92:695-701.
8. Barkan AL, Shenker Y, Grekin RJ, Vale WW, Lloyd RV, Beals TF. 1986 Acromegaly due to ectopic growth hormone (GH)-releasing hormone (GHRH) production: dynamic studies of GH and ectopic GHRH secretion. J Clin Endocrinol Metab. 63:1057-1064.
9. Frohman LA, Downs TR. 1986 Measurement of growth hormone-releasing factor. Methods Enzymol. 124:371-389.
10. Veldhuis JD, Johnson ML. 1986 Cluster analysis: a simple, versatile, and robust algorithm for endocrine pulse detection. Am J Physiol. 250:E486-E493.
11. Diggle PJ. 1990 Time series: a biostatistical introduction. Oxford: Oxford University Press; 202-221.
12. Tannenbaum GS, Ling N. 1984 The interrelationship of growth hormone (GH)-releasing factor and somatostatin in generation of the ultradian rhythm of GH secretion. Endocrinology. 115:1952-1957.
13. Moller DE, Moses AC, Jones K, Thorner MO, Vance ML. 1989 Octreotide suppresses both growth hormone (GH) and GH-releasing hormone (GHRH) in acromegaly due to ectopic GHRH secretion. J Clin Endocrinol Metab. 68:499-504.
14. Ch'ng JLC, Christofides ND, Kraenzlin ME, et al. 1985 Growth hormone secretion dynamics in a patient with ectopic growth hormone-releasing factor production. Am J Med. 79:135-138.
15. Frohman LA, Thominet JL, Webb CB, et al. 1984 Metabolic clearance and plasma disappearance rates of human pancreatic tumor growth hormone releasing factor in man. J Clin Invest. 73:1304-1311.
16. Vance ML, Kaiser DL, Rivier J, Vale W, Thorner MO. 1986 Dual effects of growth hormone (GH)-releasing hormone infusion in normal men: somatotroph desensitization and increase in releasable GH. J Clin Endocrinol Metab. 62:591-594.
17. Frohman LA, Downs TR, Williams TC, Heimer EP, Pan YC, Felix AM. 1986 Rapid enzymatic degradation of growth hormone-releasing hormone by plasma in vitro and in vivo to a biologically inactive product cleaved at the NH2 terminus. J Clin Invest. 78:906-913.
18. Frohman LA, Downs T. 1987 Ectopic GRH syndrome. In: Robbins RJ, Melmed S, eds. Acromegaly. New York: Plenum Press; 115-125.
19. Jaffe CA, DeMott-Friberg R, Barkan AL. 1996 Endogenous growth hormone-releasing hormone is required for GH responses to pharmacological stimuli. J Clin Invest. 97:934-940.
20. Christensen SE, Weeks J, Øafrskov H, Jorgensen JOL, Esman J, Doxey JC. 1987 Plasma growth hormone in acromegalic patients: demonstration of highly reproducible diurnal profiles in individual patients. Acta Endocrinol (Copenh). 116:49-52.
21. Ocampo-Lim BN, Guo W, DeMott Friberg R, et al. GH secretion pattern in acromegaly: reproducibility and diminished response to IGF-I. Proc of the 10th Int Congr of Endocrinol. 1996; 470.
22. Arnold A, Brown MF, Urena P, Gaz RD, Sarfati E, Drueke TB. 1995 Monoclonality of parathyroid tumors in chronic renal failure and in primary parathyroid hyperplasia. J Clin Invest. 95:2047-2053.
23. Melmed S. 1990 Acromegaly. N Engl J Med. 322:966-977.
24. Asa S, Scheithauer BW, Bilbao JM, et al. 1984 A case for hypothalamic acromegaly: a clinicopathological study of six patients with hypothalamic gangliocytomas producing growth hormone-releasing factor. J Clin Endocrinol Metab. 58:796-803.
25. Bevan JS, Asa SL, Rossi ML, Esiri MM, Adams CB, Burke CW. 1989 Intrasellar gangliocytoma containing gastrin and growth hormone-releasing hormone associated with a growth hormone-secreting pituitary adenoma. Clin Endocrinol (Oxf). 30:213-224.
26. Asa SL, Kovacs K, Stefaneanu L, et al. 1992 Pituitary adenomas in mice transgenic for growth hormone-releasing hormone. Endocrinology. 131:2083-2089.